Competitive enzyme-immunoassays using native viral antigens to discriminate between HIV-1 and HIV-2 infections
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 29 (1) , 81-89
- https://doi.org/10.1016/0166-0934(90)90010-d
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- ENVELOPE CROSS-REACTIVITY IN WESTERN BLOT FOR HIV-1 AND HIV-2 MAY NOT INDICATE DUAL INFECTIONThe Lancet, 1988
- Clinical, Hematologic, and Immunologic Cross-Sectional Evaluation of Individuals Exposed to Human Immunodeficiency Virus Type-2 (HIV-2)AIDS Research and Human Retroviruses, 1988
- Synthetic Peptide Immunoassay Distinguishes HIV Type 1 and HIV Type 2 InfectionsScience, 1987
- Discrimination between antibodies to HIV and to related retroviruses using site-directed serologyNature, 1987
- A STLV-III related human retrovirus, HTLV-IV: analysis of cross-reactivity with the human immunodeficiency virus (HIV)Journal of Virological Methods, 1987
- LYMPHADENOPATHY-ASSOCIATED VIRUS TYPE 2 IN AIDS AND AIDS-RELATED COMPLEXThe Lancet, 1987
- Isolation of a New Human Retrovirus from West African Patients with AIDSScience, 1986
- New Human T-Lymphotropic Retrovirus Related to Simian T-Lymphotropic Virus Type III (STLV-III AGM )Science, 1986
- SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST AFRICAThe Lancet, 1985
- Virus Envelope Protein of HTLV-III Represents Major Target Antigen for Antibodies in AIDS PatientsScience, 1985